clindamycin hydrochloride

Product NDC: 59762-5010
Requested package NDC: 59762-5010-2
11-digit product format: 597625010
Labeler code: 59762
Product ID: 59762-5010_b0325c66-cf49-4a6b-a333-06e53515832b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: clindamycin hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: NDA050162
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 1970-05-22
Marketing end: 2026-06-30
Substance: CLINDAMYCIN HYDROCHLORIDE
Active strength: 300 mg/1
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
NDC exclude flag: No
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	59762-5010	59762-5010-2	D	Discontinued by firm		2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050162-001	CLEOCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982
N050162-002	CLEOCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982
N050162-003	CLEOCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N050162-001	AB
N050162-002	AB
N050162-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050162-002	CLEOCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050162-003	CLEOCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	RLD, RS	1988-04-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050162-001	CLEOCIN HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982		`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N050162-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050162-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050162-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050162-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050162-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050162-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050162-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050162-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050162-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050162-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050162-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050162-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050162-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050162-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050162-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050162-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050162-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050162-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050162-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050162-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050162-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050162-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050162-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050162-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050162-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050162-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050162-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050162-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050162-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050162-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050162-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050162-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050162-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050162-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050162-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050162-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050162-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050162-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050162-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050162-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
1426d8f8-b7d5-4053-8554-613df00c0d86	Product name	2	20250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d8f81258-db12-0761-46cc-8ff6e62e9302	Product name	4	20240422
b7b2fa42-1c77-d724-81f0-87da60a77e79	Product name	3	20240320
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0	Product name	3	20230425
e3af9708-3004-7392-4046-5311eaa8bab5	Product name	3	20221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3	Product name	9	20220928
b72227d6-0388-43bd-995b-b762d2754cd5	Product name	1	20220706
a92d22e0-3af4-f301-bc88-27ff030b0070	Product name	2	20220316
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
5ce6ce33-4f2b-3ce0-757d-e520013280cf	Product name	5	20180719
b92a26f1-6926-4817-be73-e26ab4c2146f	Product name	1	20170602
028d6c95-5012-6976-2075-dee0ae6fefe2	Product name	1	20140508
468b2c08-8adb-8d0f-8257-c6515a061424	Product name	1	20140508
8959fb29-d86f-c521-666a-b4cb22233594	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59762-5010-1	clindamycin hydrochloride	16 in 1 BOTTLE	CAPSULE	16		35
59762-5010-2	clindamycin hydrochloride	100 in 1 BOTTLE	CAPSULE	100		35

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-5010-1	EA - Each	59762-5010	815ea5e9-1c15-4b15-8187-bcade7cae6dd	1	2012-07-24
59762-5010-2	EA - Each	59762-5010	1b2c2384-7ceb-4c5d-80df-98576d19fd90	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CLINDAMYCIN HYDROCHLORIDE	ACTIVE INGREDIENT	T20OQ1YN1W	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
CLINDAMYCIN	ACTIVE MOIETY	3U02EL437C	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CLINDAMYCIN HYDROCHLORIDE CAPSULE [GREENSTONE LLC]	10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59762-5010	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.]	32	Current NDC, Legacy NDC, 2 package rows	20250529_24595bb3-07ea-4d5f-9bb3-2c2332a1fc62.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
clindamycin hydrochloride	CLINDAMYCIN HYDROCHLORIDE	Mylan Pharmaceuticals Inc.	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	2026-04-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 050162 application number: NDA050162 ndc (package): 59762-5010-2 ndc (product): 59762-5010 ndc11 (package): 59762501002
Cleocin Hydrochloride	CLINDAMYCIN HYDROCHLORIDE	Pharmacia & Upjohn Company LLC	df9a2a41-b132-4f43-8940-b2d773b1369a	2026-04-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 050162 application number: NDA050162

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
T20OQ1YN1W	CLINDAMYCIN HYDROCHLORIDE	21462-39-5	CLINDAMYCIN HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197518	clindamycin HCl 150 MG Oral Capsule	PSN	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	35
284215	clindamycin HCl 300 MG Oral Capsule	PSN	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	35
197518	clindamycin 150 MG Oral Capsule	SCD	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	35
284215	clindamycin 300 MG Oral Capsule	SCD	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	35
197518	clindamycin (as clindamycin HCl) 150 MG Oral Capsule	SY	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	35
284215	clindamycin (as clindamycin HCl) 300 MG Oral Capsule	SY	24595bb3-07ea-4d5f-9bb3-2c2332a1fc62	35
284215	clindamycin HCl 300 MG Oral Capsule	PSN	1ad83cad-b1ed-bab9-e063-6394a90abc8a	1
284215	clindamycin 300 MG Oral Capsule	SCD	1ad83cad-b1ed-bab9-e063-6394a90abc8a	1
284215	clindamycin (as clindamycin HCl) 300 MG Oral Capsule	SY	1ad83cad-b1ed-bab9-e063-6394a90abc8a	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
59762-5010-2	59762501002	100 CAPSULE in 1 BOTTLE (59762-5010-2)	100 capsule	1970-05-22	2026-06-30	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Clindamycin Hydrochloride capsules, USP	Mylan Pharmaceuticals Inc. \| Pfizer Inc	2026-04-28	HUMAN PRESCRIPTION DRUG LABEL	35
Clindamycin Hydrochloride capsules, USP	Redpharm Drug	2024-06-14	HUMAN PRESCRIPTION DRUG LABEL	1